Imbrium Therapeutics L.P. ("Imbrium"), a subsidiary of Purdue Pharma L.P. ("Purdue"), announced results from a Phase 1b clinical signal detection study evaluating the safety and efficacy of the novel ...

Discover how cold weather can trigger prostate problems in men over 60, including frequent urination, hormonal changes, and ...

Cold weather can trigger frequent urination, hormonal changes and diuresis, especially in men over the age of 60.

Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...

Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) s ...

We’re encouraged to drink more water because ‘it’s good for us.’ Now, a new study has tested that claim, examining the evidence from previous studies to see whether increasing the amount of water you ...

The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

Medical experts share their answers to all your questions on bladder problems, from urinary tract infections to odd urine ...

Many people believe that urinary tract infections (UTIs) and incontinence are more common in women, but they can also affect ...

Urination problems affect millions of men worldwide, often developing so gradually that many dismiss early warning signs.

And Alcon Laboratories issued a voluntary nationwide recall of certain Systane Lubricant Eye Drops due to fungal ...

The US subsidiary of Japan’s Sumitomo Pharma announced that the US Food and Drug Administration (FDA) has approved Gemtesa ...